Expect more with Siegfried as your preferred partner

Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. 

Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value. 

July 13, 2015

As announced earlier, Siegfried Group (SIX:SFZN) has signed an agreement with BASF of Germany concerning the acquisition of ... Read more »

July 09, 2015

(SIX: SFZN) Siegfried and Celgene, the American bio-technology company, have put their existing close cooperation on a firm ... Read more »

SitemapRSS FeedsDisclaimer